Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

@article{Bymaster2002AtomoxetineIE,
  title={Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder},
  author={F. Bymaster and J. Katner and D. Nelson and S. Hemrick-Luecke and P. Threlkeld and J. Heiligenstein and S. Morin and D. Gehlert and K. Perry},
  journal={Neuropsychopharmacology},
  year={2002},
  volume={27},
  pages={699-711}
}
  • F. Bymaster, J. Katner, +6 authors K. Perry
  • Published 2002
  • Psychology, Medicine
  • Neuropsychopharmacology
  • The selective norepinephrine (NE) transporter inhibitor atomoxetine (formerly called tomoxetine or LY139603) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder (ADHD). We investigated the mechanism of action of atomoxetine in ADHD by evaluating the interaction of atomoxetine with monoamine transporters, the effects on extracellular levels of monoamines, and the expression of the neuronal activity marker Fos in brain regions. Atomoxetine inhibited binding of… CONTINUE READING
    922 Citations

    Paper Mentions

    Interventional Clinical Trial
    Relationships between altered prefrontal cortical dopamine, norepinephrine and some cognitive impairments of schizophrenia supports and approach for pharmacological remediation of… Expand
    ConditionsSchizophrenia
    InterventionDrug
    A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: Potential relevance to attention deficit hyperactivity disorder
    • 31
    • Highly Influenced
    • PDF

    References

    SHOWING 1-10 OF 103 REFERENCES
    Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain
    • 680
    • PDF
    Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum
    • 188
    • PDF
    Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
    • 117
    • Highly Influential
    • PDF
    Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters.
    • 201
    Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment
    • 274
    Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants.
    • 170